Kinetics of the Finasteride Prostate Induced Apoptosis
Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Unknown status
CT.gov ID
NCT00130767
Collaborator
(none)
90
1
Study Details
Study Description
Brief Summary
The aim of this study is to evaluate the mechanisms involved in the apoptosis induced by a treatment of finasteride on benign prostate hyperplasia (BPH). Five sets of patients who need a surgical procedure because of low tract urinary symptoms are randomly attributed to one of five sets of treatment: 0, 7, 14, 21 or 28 days of finasteride treatment before the day of the procedure. Prostate histological fragments are conditioned for molecular and histologic studies.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 4 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Kinetics of the Finasteride Prostate Induced Apoptosis
Study Start Date
:
Dec 1, 2004
Outcome Measures
Primary Outcome Measures
- Date of the maximum apoptosis in the prostate tissues treated by finasteride []
Secondary Outcome Measures
- Molecular mechanisms involved in BPH finasteride induced apoptosis []
- Decrease in the frequency of the hemorrhagic incidents after the surgical procedure in patients with a treatment using finasteride []
Eligibility Criteria
Criteria
Ages Eligible for Study:
40 Years
to 90 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Patients with low tract urinary symptoms needing a surgical procedure
-
No previous treatment with finasteride
-
No androgen deficiency; no prostate cancer suspected.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Centre hospitalier Lyon Sud | Pierre Bénite | France | 69495 |
Sponsors and Collaborators
- Hospices Civils de Lyon
Investigators
- Principal Investigator: Alain RUFFION, MD, Hospices Civils de Lyon
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00130767
Other Study ID Numbers:
- 2003.316
First Posted:
Aug 16, 2005
Last Update Posted:
Apr 27, 2007
Last Verified:
Apr 1, 2007
Keywords provided by ,
,
Additional relevant MeSH terms: